The global Deuterium-substituteddrugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Deuterium is the replacement of hydrogen atoms with deuterium atoms in one or more of the c-h bonds in a compound molecule.
This report aims to provide a comprehensive presentation of the global market for Deuterium-substituteddrugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Deuterium-substituteddrugs. This report contains market size and forecasts of Deuterium-substituteddrugs in global, including the following market information:
- Global Deuterium-substituteddrugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drugs in Clinical Trials Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Deuterium-substituteddrugs include Teva, Bristol-Myers Squibb, Retrotope, Alkeus, Avanir, Concert, Processa, Vertex and Jazz Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Deuterium-substituteddrugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Deuterium-substituteddrugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Deuterium-substituteddrugs Market Segment Percentages, by Type, 2022 (%)
- Drugs in Clinical Trials
- Marketed Drug
Global Deuterium-substituteddrugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Deuterium-substituteddrugs Market Segment Percentages, by Application, 2022 (%)
Global Deuterium-substituteddrugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Deuterium-substituteddrugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Deuterium-substituteddrugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Deuterium-substituteddrugs revenues share in global market, 2022 (%)
key players include:
- Teva
- Bristol-Myers Squibb
- Retrotope
- Alkeus
- Avanir
- Concert
- Processa
- Vertex
- Jazz Pharmaceuticals
- Zelgen
- Hinova Pharmaceuticals Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Deuterium-substituteddrugs, market overview.
Chapter 2: Global Deuterium-substituteddrugs market size in revenue.
Chapter 3: Detailed analysis of Deuterium-substituteddrugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Deuterium-substituteddrugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Deuterium-substituteddrugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Deuterium-substituteddrugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Deuterium-substituteddrugs Overall Market Size
2.1 Global Deuterium-substituteddrugs Market Size: 2022 VS 2032
2.2 Global Deuterium-substituteddrugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Deuterium-substituteddrugs Players in Global Market
3.2 Top Global Deuterium-substituteddrugs Companies Ranked by Revenue
3.3 Global Deuterium-substituteddrugs Revenue by Companies
3.4 Top 3 and Top 5 Deuterium-substituteddrugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Deuterium-substituteddrugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Deuterium-substituteddrugs Players in Global Market
3.6.1 List of Global Tier 1 Deuterium-substituteddrugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Deuterium-substituteddrugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Deuterium-substituteddrugs Market Size Markets, 2022 & 2032
4.1.2 Drugs in Clinical Trials
4.1.3 Marketed Drug
4.2 By Type - Global Deuterium-substituteddrugs Revenue & Forecasts
4.2.1 By Type - Global Deuterium-substituteddrugs Revenue, 2018-2023
4.2.2 By Type - Global Deuterium-substituteddrugs Revenue, 2024-2032
4.2.3 By Type - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Deuterium-substituteddrugs Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Deuterium-substituteddrugs Revenue & Forecasts
5.2.1 By Application - Global Deuterium-substituteddrugs Revenue, 2018-2023
5.2.2 By Application - Global Deuterium-substituteddrugs Revenue, 2024-2032
5.2.3 By Application - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Deuterium-substituteddrugs Market Size, 2022 & 2032
6.2 By Region - Global Deuterium-substituteddrugs Revenue & Forecasts
6.2.1 By Region - Global Deuterium-substituteddrugs Revenue, 2018-2023
6.2.2 By Region - Global Deuterium-substituteddrugs Revenue, 2024-2032
6.2.3 By Region - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Deuterium-substituteddrugs Revenue, 2018-2032
6.3.2 US Deuterium-substituteddrugs Market Size, 2018-2032
6.3.3 Canada Deuterium-substituteddrugs Market Size, 2018-2032
6.3.4 Mexico Deuterium-substituteddrugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Deuterium-substituteddrugs Revenue, 2018-2032
6.4.2 Germany Deuterium-substituteddrugs Market Size, 2018-2032
6.4.3 France Deuterium-substituteddrugs Market Size, 2018-2032
6.4.4 U.K. Deuterium-substituteddrugs Market Size, 2018-2032
6.4.5 Italy Deuterium-substituteddrugs Market Size, 2018-2032
6.4.6 Russia Deuterium-substituteddrugs Market Size, 2018-2032
6.4.7 Nordic Countries Deuterium-substituteddrugs Market Size, 2018-2032
6.4.8 Benelux Deuterium-substituteddrugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Deuterium-substituteddrugs Revenue, 2018-2032
6.5.2 China Deuterium-substituteddrugs Market Size, 2018-2032
6.5.3 Japan Deuterium-substituteddrugs Market Size, 2018-2032
6.5.4 South Korea Deuterium-substituteddrugs Market Size, 2018-2032
6.5.5 Southeast Asia Deuterium-substituteddrugs Market Size, 2018-2032
6.5.6 India Deuterium-substituteddrugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Deuterium-substituteddrugs Revenue, 2018-2032
6.6.2 Brazil Deuterium-substituteddrugs Market Size, 2018-2032
6.6.3 Argentina Deuterium-substituteddrugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, 2018-2032
6.7.2 Turkey Deuterium-substituteddrugs Market Size, 2018-2032
6.7.3 Israel Deuterium-substituteddrugs Market Size, 2018-2032
6.7.4 Saudi Arabia Deuterium-substituteddrugs Market Size, 2018-2032
6.7.5 UAE Deuterium-substituteddrugs Market Size, 2018-2032
7 Deuterium-substituteddrugs Companies Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Deuterium-substituteddrugs Major Product Offerings
7.1.4 Teva Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Deuterium-substituteddrugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Retrotope
7.3.1 Retrotope Company Summary
7.3.2 Retrotope Business Overview
7.3.3 Retrotope Deuterium-substituteddrugs Major Product Offerings
7.3.4 Retrotope Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.3.5 Retrotope Key News & Latest Developments
7.4 Alkeus
7.4.1 Alkeus Company Summary
7.4.2 Alkeus Business Overview
7.4.3 Alkeus Deuterium-substituteddrugs Major Product Offerings
7.4.4 Alkeus Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.4.5 Alkeus Key News & Latest Developments
7.5 Avanir
7.5.1 Avanir Company Summary
7.5.2 Avanir Business Overview
7.5.3 Avanir Deuterium-substituteddrugs Major Product Offerings
7.5.4 Avanir Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.5.5 Avanir Key News & Latest Developments
7.6 Concert
7.6.1 Concert Company Summary
7.6.2 Concert Business Overview
7.6.3 Concert Deuterium-substituteddrugs Major Product Offerings
7.6.4 Concert Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.6.5 Concert Key News & Latest Developments
7.7 Processa
7.7.1 Processa Company Summary
7.7.2 Processa Business Overview
7.7.3 Processa Deuterium-substituteddrugs Major Product Offerings
7.7.4 Processa Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.7.5 Processa Key News & Latest Developments
7.8 Vertex
7.8.1 Vertex Company Summary
7.8.2 Vertex Business Overview
7.8.3 Vertex Deuterium-substituteddrugs Major Product Offerings
7.8.4 Vertex Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.8.5 Vertex Key News & Latest Developments
7.9 Jazz Pharmaceuticals
7.9.1 Jazz Pharmaceuticals Company Summary
7.9.2 Jazz Pharmaceuticals Business Overview
7.9.3 Jazz Pharmaceuticals Deuterium-substituteddrugs Major Product Offerings
7.9.4 Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.9.5 Jazz Pharmaceuticals Key News & Latest Developments
7.10 Zelgen
7.10.1 Zelgen Company Summary
7.10.2 Zelgen Business Overview
7.10.3 Zelgen Deuterium-substituteddrugs Major Product Offerings
7.10.4 Zelgen Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.10.5 Zelgen Key News & Latest Developments
7.11 Hinova Pharmaceuticals Inc.
7.11.1 Hinova Pharmaceuticals Inc. Company Summary
7.11.2 Hinova Pharmaceuticals Inc. Business Overview
7.11.3 Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Major Product Offerings
7.11.4 Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue in Global Market (2018-2023)
7.11.5 Hinova Pharmaceuticals Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Deuterium-substituteddrugs Market Opportunities & Trends in Global Market
Table 2. Deuterium-substituteddrugs Market Drivers in Global Market
Table 3. Deuterium-substituteddrugs Market Restraints in Global Market
Table 4. Key Players of Deuterium-substituteddrugs in Global Market
Table 5. Top Deuterium-substituteddrugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Deuterium-substituteddrugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Deuterium-substituteddrugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Deuterium-substituteddrugs Product Type
Table 9. List of Global Tier 1 Deuterium-substituteddrugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Deuterium-substituteddrugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Deuterium-substituteddrugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Deuterium-substituteddrugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Deuterium-substituteddrugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Deuterium-substituteddrugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Deuterium-substituteddrugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Deuterium-substituteddrugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue, (US$, Mn), 2024-2032
Table 30. Teva Company Summary
Table 31. Teva Deuterium-substituteddrugs Product Offerings
Table 32. Teva Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Key News & Latest Developments
Table 34. Bristol-Myers Squibb Company Summary
Table 35. Bristol-Myers Squibb Deuterium-substituteddrugs Product Offerings
Table 36. Bristol-Myers Squibb Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 37. Bristol-Myers Squibb Key News & Latest Developments
Table 38. Retrotope Company Summary
Table 39. Retrotope Deuterium-substituteddrugs Product Offerings
Table 40. Retrotope Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 41. Retrotope Key News & Latest Developments
Table 42. Alkeus Company Summary
Table 43. Alkeus Deuterium-substituteddrugs Product Offerings
Table 44. Alkeus Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 45. Alkeus Key News & Latest Developments
Table 46. Avanir Company Summary
Table 47. Avanir Deuterium-substituteddrugs Product Offerings
Table 48. Avanir Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 49. Avanir Key News & Latest Developments
Table 50. Concert Company Summary
Table 51. Concert Deuterium-substituteddrugs Product Offerings
Table 52. Concert Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 53. Concert Key News & Latest Developments
Table 54. Processa Company Summary
Table 55. Processa Deuterium-substituteddrugs Product Offerings
Table 56. Processa Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 57. Processa Key News & Latest Developments
Table 58. Vertex Company Summary
Table 59. Vertex Deuterium-substituteddrugs Product Offerings
Table 60. Vertex Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 61. Vertex Key News & Latest Developments
Table 62. Jazz Pharmaceuticals Company Summary
Table 63. Jazz Pharmaceuticals Deuterium-substituteddrugs Product Offerings
Table 64. Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 65. Jazz Pharmaceuticals Key News & Latest Developments
Table 66. Zelgen Company Summary
Table 67. Zelgen Deuterium-substituteddrugs Product Offerings
Table 68. Zelgen Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 69. Zelgen Key News & Latest Developments
Table 70. Hinova Pharmaceuticals Inc. Company Summary
Table 71. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Product Offerings
Table 72. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue (US$, Mn) & (2018-2023)
Table 73. Hinova Pharmaceuticals Inc. Key News & Latest Developments
List of Figures
Figure 1. Deuterium-substituteddrugs Segment by Type in 2022
Figure 2. Deuterium-substituteddrugs Segment by Application in 2022
Figure 3. Global Deuterium-substituteddrugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Deuterium-substituteddrugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Deuterium-substituteddrugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Deuterium-substituteddrugs Revenue in 2022
Figure 8. By Type - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Deuterium-substituteddrugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 16. US Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 20. Germany Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 28. China Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 34. Brazil Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Deuterium-substituteddrugs Revenue Market Share, 2018-2032
Figure 37. Turkey Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Deuterium-substituteddrugs Revenue, (US$, Mn), 2018-2032
Figure 41. Teva Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol-Myers Squibb Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Retrotope Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Alkeus Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Avanir Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Concert Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Processa Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Vertex Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Jazz Pharmaceuticals Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zelgen Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hinova Pharmaceuticals Inc. Deuterium-substituteddrugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
